Magnetic Insight Company

Magnetic Insight (MI) introduced magnetic particle imaging into the preclinical diagnostic research market enabling quantitative cell tracking, imaging of vascular function, detecting metastatic tumors, visualizing inflammation, CAR-T cell therapies and initial research into regenerative medicine.
Magnetic Particle Imaging (MPI) is a new imaging modality that directly detects iron oxide nanoparticle tracers using time-varying magnetic fields. Because the tracer is not normally found in the body, MPI images have exceptional contrast and high sensitivity.
Magnetic Particle Imaging uses a unique geometry of magnetics to create a field free region (FFR). This is something you may have experienced when pointing two magnets at each other. That sensitive point controls the direction of a nanoparticle.

Investors

Founded Date: 2014
Last Funding Type: Series A
Headquarters: United States
Investors Number: 9
Technology: MarketPlace
Employee Number: 11-50
Industry: P4 Medicine
Estimated Revenue: $1M to $10M
Number Of Exists: N/A
Funding Status: Early Stage Venture
Investor Type: N/A
Investment Stage: N/A
Total Funding: $25.6M
Register and Claim Ownership